title: [Therapy of tuberculosis and other mycobacterial infections].
abstract: At present every case of tuberculosis recognized in time is curable. The antituberculotic remedies have a causal effect, since they achieve a destruction of the germs. Decisive for the success are the observing of the treatment instructions and the cooperation with the patient in a period of 6-9 months. The action mode of the basic pharmaceutic agents, the dynamics of bacterial populations and the newest therapy recommendations are listed in tables. In the case of leprosy we look forward to similar results. Here the chemotherapy must, however, be performed for 2 years and longer. In the Buruli-ulcer (mycobacterial skin ulcer) after additional surgical interventions are still to be recommended. Mycobacterioses caused by other human-pathogenic atypical mycobacteria are also cured by a specific treatment of 1-2 years. In particular cases resection are still necessary.
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy; D009164:Mycobacterium Infections / Q000188:drug therapy*; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy; D012883:Skin Ulcer / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D007917:Leprostatic Agents
vernacular_title: Therapie der Tuberkulose und anderer Mykobakteriosen.